{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T11:25:36Z","timestamp":1773833136978,"version":"3.50.1"},"reference-count":10,"publisher":"Chinese Center for Disease Control and Prevention","issue":"50","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.46234\/ccdcw2024.264","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T11:21:08Z","timestamp":1734088868000},"page":"1331-1336","source":"Crossref","is-referenced-by-count":1,"title":["Immunogenicity of Short-Course, High-Dose Hepatitis B Vaccination in Patients with Chronic Kidney Disease \u2014 Shanxi Province, China, 2019\u20132020"],"prefix":"10.46234","volume":"6","author":[{"given":"Linying","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"School of Public Health, Shanxi Medical University, Taiyuan City, Shanxi Province, China","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xufeng","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyuan","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaoyue","family":"Men","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuyang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianmin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongping","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guowei","family":"Chai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuzhen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofeng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongliang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Key Laboratory of Coal Environmental Pathogenicity and Prevention (Shanxi Medical University), Ministry of Education, Taiyuan City, Shanxi Province, China","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Center of Clinical Epidemiology and Evidence Based Medicine, Shanxi Medical University, Taiyuan City, Shanxi Province, China","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"First Hospital\/First Clinical Medical College of Shanxi Medical University, Taiyuan City, Shanxi Province, China","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Nephrology, Linfen Central Hospital, Linfen City, Shanxi Province, China","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Nephrology, Yuncheng Central Hospital, Yuncheng City, Shanxi Province, China","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Nephrology, Linfen People\u2019s Hospital, Linfen City, Shanxi Province, China","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Nephrology, Houma People\u2019s Hospital, Houma City, Shanxi Province, China","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Institute of Vaccine Industry, Jinan University, Guangzhou City, Guangdong Province, China","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Institute of Disease Control and Prevention, Jinan University, Guangzhou City, Guangdong Province, China","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Chinese Preventive Medicine Association, Beijing, China","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"25413","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Windpessl M, Heine GH, Becker SL, Scheuer AL, Sester M, Kronbichler A. The impact of immunosuppression and chronic kidney disease on immunogenicity of COVID-19 vaccines. Dtsch Med Wochenschr 2021;146(19):1277 \u2212 82. https:\/\/doi.org\/10.1055\/A-1550-7288.","DOI":"10.1055\/a-1550-7288"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Papp KA, Haraoui B, Kumar D, Marshall JK, Bissonnette R, Bitton A, et al. Vaccination guidelines for patients with immune-mediated disorders taking immunosuppressive therapies: executive summary. J Rheumatol 2019;46(7):751 \u2212 4. https:\/\/doi.org\/10.3899\/jrheum.180784.","DOI":"10.3899\/jrheum.180784"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Habib MB, Ali K, Rahhal A, Obeidat I, Altermanini M, Sawaf B, et al. Determinants of vaccine adherence among non-dialysis chronic kidney disease patients in Qatar. Qatar Med J 2024;2023(4):33. https:\/\/doi.org\/10.5339\/qmj.2023.33.","DOI":"10.5339\/qmj.2023.33"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Krueger KM, Ison MG, Ghossein C. Practical guide to vaccination in all stages of CKD, including patients treated by dialysis or kidney transplantation. Am J Kidney Dis 2020;75(3):417 \u2212 25. https:\/\/doi.org\/10.1053\/j.ajkd.2019.06.014.","DOI":"10.1053\/j.ajkd.2019.06.014"},{"key":"5","unstructured":"Chinese Society of Hepatology, Chinese Medical Association, Chinese Society of Infectious Diseases, Chinese Medical Association. Guidelines for the prevention and treatment of chronic hepatitis B (version 2022). Chin J Clin Infect Dis 2022;15(6):401 \u2212 27. https:\/\/doi.org\/10.3760\/cma.j.issn.1674-2397.2022.06.001."},{"key":"6","doi-asserted-by":"crossref","unstructured":"Zhang X, Wang J, Chen X, Yu ML, Yu SB, Sun YY, et al. Short-term immunogenicity of standard and accelerated hepatitis B virus vaccination schedules in healthy adults: a comparative field study in China. Biosci Rep 2018;38(5):BSR20180846. https:\/\/doi.org\/10.1042\/BSR20180846.","DOI":"10.1042\/BSR20180846"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Wang J, Liu CH, Ma YJ, Zhu X, Luo LR, Ji YL, et al. Two-year immune effect differences between the 0-1-2-month and 0-1-6-month HBV vaccination schedule in adults. BMC Infect Dis 2022;22(1):159. https:\/\/doi.org\/10.1186\/s12879-022-07151-6.","DOI":"10.1186\/s12879-022-07151-6"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Hwang LY, Grimes CZ, Tran TQ, Clark A, Xia P, Lai DJ, et al. Accelerated hepatitis B vaccination schedule among drug users: a randomized controlled trial. J Infect Dis 2010;202(10):1500 \u2212 9. https:\/\/doi.org\/10.1086\/656776.","DOI":"10.1086\/656776"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Vargas JI, Jensen D, Mart\u00ednez F, Sarmiento V, Peirano F, Acu\u00f1a P, et al. Comparative efficacy of a high-dose vs standard-dose hepatitis B revaccination schedule among patients with HIV: a randomized clinical trial. JAMA Netw Open 2021;4(8):e2120929. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.20929.","DOI":"10.1001\/jamanetworkopen.2021.20929"},{"key":"10","unstructured":"Feng YL, Han YJ, Yao T, Wang JM, Liu HT, Guo HP, et al. Immunogenicity and influencing factors of hepatitis B vaccination based on different vaccination schedules among chronic kidney disease patients. Chin J Epidemiol 2022;43(2):241 \u2212 7. https:\/\/doi.org\/10.3760\/cma.j.cn112338-20210807-00618."}],"container-title":["China CDC Weekly"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/weekly.chinacdc.cn\/en\/article\/pdf\/preview\/10.46234\/ccdcw2024.264","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T11:37:49Z","timestamp":1734089869000},"score":1,"resource":{"primary":{"URL":"https:\/\/weekly.chinacdc.cn\/en\/article\/doi\/10.46234\/ccdcw2024.264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":10,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.46234\/ccdcw2024.264","relation":{},"ISSN":["2097-3101"],"issn-type":[{"value":"2097-3101","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]}}}